SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001319244-15-000027
Filing Date
2015-04-10
Accepted
2015-04-10 17:06:14
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ASPX_sc13d.htm.htm SC 13D 5857390
  Complete submission text file 0001319244-15-000027.txt   5859414
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037
Business Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Subject) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87930 | Film No.: 15765050
SIC: 2834 Pharmaceutical Preparations